Piramal Pharma Price to Cash Flow Ratio

Piramal Pharma Ltd Price to Cash Flow Ratio

The Piramal Pharma Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Piramal Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Piramal Pharma Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Piramal Pharma Ltd (NSE: PPLPHARMA, BSE: 543635) is currently trading at ₹138.35, with a market capitalization of ₹183.77B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Piramal Pharma Ltd Price to Cash Flow Ratio is essential for fundamental analysis.

Piramal Pharma Ltd Price to Cash Flow Ratio Current Value

The current Piramal Pharma Ltd Price to Cash Flow Ratio stands at 59.72.

The latest Piramal Pharma Ltd Price to Cash Flow Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Piramal Pharma Ltd Price to Cash Flow Ratio Historical Trend

The Piramal Pharma Ltd Price to Cash Flow Ratio has shown the following historical trend:

• 2024: 59.72
• 2023: 29.29
• 2022: 28.25
• 2021: 0

The recent rise in Piramal Pharma Ltd Price to Cash Flow Ratio suggests strengthening valuation trends and improving market sentiment.

What Piramal Pharma Ltd Price to Cash Flow Ratio Indicates for Investors

The Piramal Pharma Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/CF ratio indicates how much investors pay for company cash flow.

Piramal Pharma Ltd Price to Cash Flow Ratio Analysis Summary

The Piramal Pharma Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Piramal Pharma Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Piramal Pharma Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.